Despite the excitement generated by the recent discovery of FOXL2 and DICER1 as key tumor suppressors in pediatric ovarian cancers, there is still much to be understood regarding the mechanisms by which these events lead to cancer. This evidence concerns the gene FOXL2 and cancer.